Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis

Molecular Neurobiology

Volumn 53, Issue 3, 2016, Pages 1770-1781

  Barichello, Tatiana ^a,b   Generoso, Jaqueline S ^b   Simões, Lutiana R ^b   Goularte, Jessica A ^b   Petronilho, Fabricia ^a,b   Saigal, Priyanka ^a   Badawy, Marwa ^a   Quevedo, João ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Bacterial meningitis; Cytokines; DAMPs; Microglia; Oxidative stress; PAMPs

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL FACTOR; BOX A PROTEIN; CEFTRIAXONE; DANGER ASSOCIATED MOLECULAR PATTERN; ETHYLPYRUVIC ACID; FRACTALKINE; HMGB1 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 34; MINOCYCLINE; PALMIDROL; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PROTEIN ANTIBODY; PROTEIN S 100; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG;

BACTERIAL MENINGITIS; BORRELIA BURGDORFERI; CELL ACTIVATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; MESENCHYME CELL; MICROGLIA; NEISSERIA MENINGITIDIS; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHENOTYPE; PNEUMOCOCCAL MENINGITIS; REVIEW; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TRAUMATIC BRAIN INJURY; ANIMAL; CELL SHAPE; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANIMALS; CELL SHAPE; HUMANS; MENINGITIS, BACTERIAL; MICROGLIA; MOLECULAR TARGETED THERAPY; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; SIGNAL TRANSDUCTION;

EID: 84961153903     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9107-4     Document Type: Review

References (113)

1. Hoogman M, van de Beek D, Weisfelt M, de Gans J, Schmand B (2007) Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry 78(10):1092–1096
2. Merkelbach S, Sittinger H, Schweizer I, Muller M (2000) Cognitive outcome after bacterial meningitis. Acta Neurol Scand 102(2):118–123
3. Sellner J, Täuber MG, Leib SL (2010) Chapter 1—pathogenesis and pathophysiology of bacterial CNS infections. In: Karen LR, Allan RT (eds) Handbook of clinical neurology. Elsevier, New York, pp 1–16
4. Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D (2011) Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 24(3):557–591
5. Savva A, Roger T (2013) Targeting Toll-Like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol 4:387
6. Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327(5963):291–295
7. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T (2014) Host innate immune responses to sepsis. Virulence 5(1):36–44
8. Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ, Wang H (2014) Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol 10(6):713–727
9. Barichello T, Generoso JS, Milioli G, Elias SG, Teixeira AL (2013) Pathophysiology of bacterial infection of the central nervous system and its putative role in the pathogenesis of behavioral changes. Rev Bras Psiquiatr 35(1):81–87
10. Hu X, Liou AK, Leak RK, Xu M, An C, Suenaga J, Shi Y, Gao Y et al (2014) Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog Neurobiol 119–120:60–84
11. Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11(11):775–787
12. Benarroch EE (2013) Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology 81(12):1079–1088
13. Stence N, Waite M, Dailey ME (2001) Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33(3):256–266
14. Yamada J, Jinno S (2013) Novel objective classification of reactive microglia following hypoglossal axotomy using hierarchical cluster analysis. J Comp Neurol 521(5):1184–1201
15. Boche D, Perry VH, Nicoll JA (2013) Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39(1):3–18
16. Suzumura A (2013) Neuron-microglia interaction in neuroinflammation. Curr Protein Pept Sci 14(1):16–20
17. Moore KJ, Sheedy FJ, Fisher EA (2013) Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13(10):709–721
18. Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, Chen J (2015) Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol 11(1):56–64
19. Hohne C, Wenzel M, Angele B, Hammerschmidt S, Hacker H, Klein M, Bierhaus A, Sperandio M et al (2013) High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis. Brain 136(Pt 6):1746–1759
20. Okuma Y, Date I, Nishibori M (2014) Anti-high mobility group Box-1 antibody therapy for traumatic brain injury. Yakugaku Zasshi 134(6):701–705
21. Zhu F, Zheng Y, Ding YQ, Liu Y, Zhang X, Wu R, Guo X, Zhao J (2014) Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats. PLoS One 9(4):e93966
22. Dworak M, Stebbing M, Kompa AR, Rana I, Krum H, Badoer E (2014) Attenuation of microglial and neuronal activation in the brain by ICV minocycline following myocardial infarction. Auton Neurosci 185:43–50
23. Schmitz T, Krabbe G, Weikert G, Scheuer T, Matheus F, Wang Y, Mueller S, Kettenmann H et al (2014) Minocycline protects the immature white matter against hyperoxia. Exp Neurol 254:153–165
24. Seabrook TJ, Jiang L, Maier M, Lemere CA (2006) Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 53(7):776–782
25. Sheu JN, Liao WC, Wu UI, Shyu LY, Mai FD, Chen LY, Chen MJ, Youn SC et al (2013) Resveratrol suppresses calcium-mediated microglial activation and rescues hippocampal neurons of adult rats following acute bacterial meningitis. Comp Immunol Microbiol Infect Dis 36(2):137–148
26. Paolicelli RC, Bisht K, Tremblay ME (2014) Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci 8:129
27. Mattison HA, Nie H, Gao H, Zhou H, Hong JS, Zhang J (2013) Suppressed proinflammatory response of microglia in CX3CR1 knockout mice. J Neuroimmunol 257(1–2):110–115
28. Zanier ER, Pischiutta F, Riganti L, Marchesi F, Turola E, Fumagalli S, Perego C, Parotto E et al (2014) Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma. Neurotherapeutics 11(3):679–695
29. Norden DM, Fenn AM, Dugan A, Godbout JP (2014) TGFbeta produced by IL-10 redirected astrocytes attenuates microglial activation. Glia 62(6):881–895
30. Rasley A, Tranguch SL, Rati DM, Marriott I (2006) Murine glia express the immunosuppressive cytokine, interleukin-10, following exposure to Borrelia burgdorferi or Neisseria meningitidis. Glia 53(6):583–592
31. Jin S, Sonobe Y, Kawanokuchi J, Horiuchi H, Cheng Y, Wang Y, Mizuno T, Takeuchi H, Suzumura A (2014) Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells. PLoS One 9(12):e115981
32. Redlich S, Ribes S, Schutze S, Nau R (2014) Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections. J Neuroinflammation 11:108
33. Gaikwad SM, Heneka MT (2013) Studying M1 and M2 states in adult microglia. Methods Mol Biol 1041:185–197
34. Koedel U (2009) Toll-like receptors in bacterial meningitis. Curr Top Microbiol Immunol 336:15–40
35. Wang Z, Wesche H, Stevens T, Walker N, Yeh WC (2009) IRAK-4 inhibitors for inflammation. Curr Top Med Chem 9(8):724–737
36. Takeda K, Akira S (2007) Toll-like receptors. Curr Protoc Immunol Chapter 14: p Unit 14.12
37. Koedel U, Rupprecht T, Angele B, Heesemann J, Wagner H, Pfister HW, Kirschning CJ (2004) MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain 127(Pt 6):1437–1445
38. Prinz M, Priller J (2014) Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15(5):300–312
39. Tato CM, Hunter CA (2002) Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun 70(7):3311–3317
40. Kastenbauer S, Koedel U, Weih F, Ziegler-Heitbrock L, Pfister HW (2004) Protective role of NF-kappaB1 (p50) in experimental pneumococcal meningitis. Eur J Pharmacol 498(1–3):315–318
41. Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW (2000) Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis. J Infect Dis 182(5):1437–1445
42. Kigerl KA, de Rivero Vaccari JP, Dietrich WD, Popovich PG, Keane RW (2014) Pattern recognition receptors and central nervous system repair. Exp Neurol 258:5–16
43. Damgaard RB, Gyrd-Hansen M (2011) Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity. Discov Med 11(58):221–231
44. Kumar S, Ingle H, Prasad DV, Kumar H (2013) Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol 39(3):229–246
45. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16(2):228–231
46. Liu X, Chauhan VS, Young AB, Marriott I (2010) NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae. Glia 58(7):839–847
47. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C, Reppe K, Meixenberger K et al (2011) The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187(1):434–440
48. Gombault A, Baron L, Couillin I (2012) ATP release and purinergic signaling in NLRP3 inflammasome activation. Front Immunol 3:414
49. Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM (1991) Recombinant human interleukin-1 induces meningitis and blood–brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 87(4):1360–1366
50. Zwijnenburg PJ, van der Poll T, Florquin S, Roord JJ, Van Furth AM (2003) IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis. J Immunol 170(9):4724–4730
51. Zwijnenburg PJ, van der Poll T, Florquin S, Akira S, Takeda K, Roord JJ, van Furth AM (2003) Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis. J Neuroimmunol 138(1–2):31–37
52. Hoegen T, Tremel N, Klein M, Angele B, Wagner H, Kirschning C, Pfister HW, Fontana A et al (2011) The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 187(10):5440–5451
53. Samways DS, Li Z, Egan TM (2014) Principles and properties of ion flow in P2X receptors. Front Cell Neurosci 8:6
54. Harris HE, Andersson U, Pisetsky DS (2012) HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8(4):195–202
55. Tobon-Velasco JC, Cuevas E, Torres-Ramos MA, Santamaria A (2014) Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets 13(9):1615–1626
56. Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B et al (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82(2):380–397
57. Zelante T, Ricciardi-Castagnoli P (2012) The yin-yang nature of CSF1R-binding cytokines. Nat Immunol 13(8):717–719
58. Nakamichi Y, Udagawa N, Takahashi N (2013) IL-34 and CSF-1: similarities and differences. J Bone Miner Metab 31(5):486–495
59. Cherry JD, Olschowka JA, O’Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11(1):98
60. Appel SH, Beers DR, Henkel JS (2010) T cell-microglial dialogue in Parkinson’s disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol 31(1):7–17
61. Varnum MM, Ikezu T (2012) The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer’s disease brain. Arch Immunol Ther Exp (Warsz) 60(4):251–266
62. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677–686
63. Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181(6):3733–3739
64. Suzumura A, Sawada M, Yamamoto H, Marunouchi T (1993) Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151(4):2150–2158
65. Zhou X, Spittau B, Krieglstein K (2012) TGFbeta signalling plays an important role in IL4-induced alternative activation of microglia. J Neuroinflammation 9:210
66. Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, Sawaya R, Heimberger AB (2010) Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 12(11):1113–1125
67. Pourcet B, Pineda-Torra I (2013) Transcriptional regulation of macrophage arginase 1 expression and its role in atherosclerosis. Trends Cardiovasc Med 23(5):143–152
68. Striz I, Brabcova E, Kolesar L, Sekerkova A (2014) Cytokine networking of innate immunity cells: a potential target of therapy. Clin Sci (Lond) 126(9):593–612
69. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958–969
70. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW (2001) Interleukin-10 in the brain. Crit Rev Immunol 21(5):427–449
71. Genovese T, Esposito E, Mazzon E, Di Paola R, Caminiti R, Bramanti P, Cappelani A, Cuzzocrea S (2009) Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem 108(6):1360–1372
72. Thompson CD, Zurko JC, Hanna BF, Hellenbrand DJ, Hanna A (2013) The therapeutic role of interleukin-10 after spinal cord injury. J Neurotrauma 30(15):1311–1324
73. Grandgirard D, Leib SL (2010) Meningitis in neonates: bench to bedside. Clin Perinatol 37(3):655–676
74. van de Beek D, Drake JM, Tunkel AR (2010) Nosocomial bacterial meningitis. N Engl J Med 362(2):146–154
75. Coutinho LG, Grandgirard D, Leib SL, Agnez-Lima LF (2013) Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis. BMC Infect Dis 13(1):326
76. Sharief MK, Ciardi M, Thompson EJ (1992) Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis 166(2):350–358
77. Barichello T, dos Santos I, Savi GD, Simoes LR, Silvestre T, Comim CM, Sachs D, Teixeira MM et al (2010) TNF-alpha, IL-1beta, IL-6, and cinc-1 levels in rat brain after meningitis induced by Streptococcus pneumoniae. J Neuroimmunol 221(1–2):42–45
78. Barichello T, Lemos JC, Generoso JS, Cipriano AL, Milioli GL, Marcelino DM, Vuolo F, Petronilho F et al (2011) Oxidative stress, cytokine/chemokine and disruption of blood–brain barrier in neonate rats after meningitis by Streptococcus agalactiae. Neurochem Res 36(10):1922–1930
79. Tsao N, Chang WW, Liu CC, Lei HY (2002) Development of hematogenous pneumococcal meningitis in adult mice: the role of TNF-alpha. FEMS Immunol Med Microbiol 32(2):133–140
80. Gerber J, Bottcher T, Hahn M, Siemer A, Bunkowski S, Nau R (2004) Increased mortality and spatial memory deficits in TNF-alpha-deficient mice in ceftriaxonetreated experimental pneumococcal meningitis. Neurobiol Dis 16(1):133–138
81. Klein M, Koedel U, Pfister HW (2006) Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? Prog Neurobiol 80(6):269–280
82. Radi R (2013) Peroxynitrite, a stealthy biological oxidant. J Biol Chem 288(37):26464–26472
83. Radi R (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101(12):4003–4008
84. Matata BM, Galinanes M (2002) Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity. J Biol Chem 277(3):2330–2335
85. Srivastava R, Lohokare R, Prasad R (2013) Oxidative stress in children with bacterial meningitis. J Trop Pediatr 59(4):305–308
86. Barichello T, Generoso JS, Simoes LR, Elias SG, Quevedo J (2013) Role of oxidative stress in the pathophysiology of pneumococcal meningitis. Oxidative Med Cell Longev 2013:371465
87. Barichello T, Savi GD, Silva GZ, Generoso JS, Bellettini G, Vuolo F, Petronilho F, Feier G et al (2010) Antibiotic therapy prevents, in part, the oxidative stress in the rat brain after meningitis induced by Streptococcus pneumoniae. Neurosci Lett 478(2):93–96
88. Barichello T, Savi GD, Simoes LR, Generoso JS, Fraga DB, Bellettini G, Daufenbach JF, Rezin GT et al (2010) Evaluation of mitochondrial respiratory chain in the brain of rats after pneumococcal meningitis. Brain Res Bull 82(5–6):302–307
89. Kastenbauer S, Koedel U, Becker BF, Pfister HW (2002) Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy. Eur J Pharmacol 449(1–2):177–181
90. Barichello T, Santos AL, Savi GD, Generoso JS, Otaran P, Michelon CM, Steckert AV, Mina F et al (2012) Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats. Metab Brain Dis 27(4):587–593
91. Tang D, Kang R, Cao L, Zhang G, Yu Y, Xiao W, Wang H, Xiao X (2008) A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Crit Care Med 36(1):291–295
92. Kang R, Cao LZ, Tang DL, Zhang GY, Yu Y, Xiao XZ (2007) Significance of heat shock protein 70 in cerebrospinal fluid in differential diagnosis of central nervous system infection in children. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19(6):346–348
93. Tukaj S (2014) Immunoregulatory properties of Hsp70. Postepy Hig Med Dosw (Online) 68:722–727
94. Yenari MA, Liu J, Zheng Z, Vexler ZS, Lee JE, Giffard RG (2005) Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann N Y Acad Sci 1053:74–83
95. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL (2013) Functions of S100 proteins. Curr Mol Med 13(1):24–57
96. Gazzolo D, Grutzfeld D, Michetti F, Toesca A, Lituania M, Bruschettini M, Dobrzanska A, Bruschettini P (2004) Increased S100B in cerebrospinal fluid of infants with bacterial meningitis: relationship to brain damage and routine cerebrospinal fluid findings. Clin Chem 50(5):941–944
97. Kepa L, Oczko-Grzesik B (2013) Evaluation of cerebrospinal fluid S100B protein concentration in patients with purulent, bacterial meningitis—own observations. Przegl Epidemiol 67(3):415–419, 525-8
98. Zhang LY, Li Y, Jin MF (2014) Diagnostic values of neopterin and S100b for central nervous system infections in children. Zhongguo Dang Dai Er Ke Za Zhi 16(4):380–383
99. Schmidt H, Gerber J, Stuertz K, Djukic M, Bunkowski S, Fischer FR, Otto M, Nau R (2010) S100B in the cerebrospinal fluid–a marker for glial damage in the rabbit model of pneumococcal meningitis. Neurosci Lett 475(2):104–107
100. Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, Edwards M, Rosmalen CF et al (2010) GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 75(20):1786–1793
101. Shin SH, Kim KS (2012) Treatment of bacterial meningitis: an update. Expert Opin Pharmacother 13(15):2189–2206
102. Li C, Yuan K, Schluesener H (2013) Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis. Rev Neurosci 24(5):553–562
103. Keller WR, Kum LM, Wehring HJ, Koola MM, Buchanan RW, Kelly DL (2013) A review of anti-inflammatory agents for symptoms of schizophrenia. J Psychopharmacol 27(4):337–342
104. Zhang F, Liu J, Shi JS (2010) Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 636(1–3):1–7
105. Kastenbauer S, Koedel U, Wick M, Kieseier BC, Hartung HP, Pfister HW (2003) CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J Neuroimmunol 137(1–2):210–217
106. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G et al (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9(7):917–924
107. Tena A, Sachs DH (2014) Stem cells: immunology and immunomodulation. Dev Ophthalmol 53:122–132
108. van Velthoven CT, Sheldon RA, Kavelaars A, Derugin N, Vexler ZS, Willemen HL, Maas M, Heijnen CJ et al (2013) Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44(5):1426–1432
109. Wang Y, Colonna M (2014) Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells. Eur J Immunol 44(6):1575–1581
110. Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, Halenbeck R, Wu G et al (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320(5877):807–811
111. Muccioli GG, Stella N (2008) Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology 54(1):16–22
112. Redlich S, Ribes S, Schutze S, Czesnik D, Nau R (2012) Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 and Streptococcus pneumoniae R6 by microglial cells. J Neuroimmunol 244(1–2):32–34
113. Nau R, Ribes S, Djukic M, Eiffert H (2014) Strategies to increase the activity of microglia as efficient protectors of the brain against infections. Front Cell Neurosci 8:138